County of Upshur v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:17-op-45085 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Dec 15, 2017 |
| Case in other court: | Texas Eastern, 2:17-cv-00672 |
| Last checked: Friday Nov 08, 2019 4:59 PM EST |
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Morris & Dickson Co., LLC
|
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Pharmacy Buying Association, Inc.
|
|
|
Defendant
Purdue Frederick Company
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Knoll Pharmaceutical Company
|
Represented By
|
|
Defendant
Sandoz Inc.
|
|
|
Defendant
Smith Drug Company
|
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Wal-Mart Stores Texas, LLC
|
|
|
Defendant
Walmart Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Does 1-100, Inclusive
|
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Hikma Pharmaceuticals USA Inc.
|
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Plaintiff
County of Upshur
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Pfizer Inc
Terminated: 11/16/2017
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
Terminated: 04/11/2018
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Abbott Laboratories
Terminated: 03/01/2018
|
Represented By
|
|
Defendant
Cephalon Inc.
Terminated: 04/11/2018
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
Terminated: 03/24/2018
|
Represented By
|
| Docket last updated: 04/08/2019 5:51 PM EDT |
| Friday, September 29, 2017 | ||
| Case Assigned to Judge Rodney Gilstrap. (nkl, ) [Transferred from txed on 12/15/2017.] | ||
| In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form[LINK:Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge . (nkl, ) [Transferred from txed on 12/15/2017.] | ||
| 1 | 1
58
pgs
COMPLAINT AND JURY DEMAND against All Defendants ( Filing fee $ 400 receipt number 0540-6487508.), filed by County of Upshur.(Nowell, Erin) [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Civil Cover Sheet
|
||
| 2 | 2
NOTICE of Attorney Appearance by John F Walker on behalf of County of Upshur (Walker, John) [Transferred from txed on 12/15/2017.]
|
|
| 3 | 3
NOTICE of Attorney Appearance by Reid William Martin on behalf of County of Upshur (Martin, Reid) [Transferred from txed on 12/15/2017.]
|
|
| 4 | 4
SUMMONS Issued as to Abbott Laboratories c/o CT Corporation System, Actavis LLC c/o Corporate Creations Network, Inc., Actavis Pharma, Inc. c/o CT Corporation System, Allergan Finance LLC c/o The Corporation Trust Company of Nevada, AmerisourceBergen Corporation c/o The Corporation Trust Company Corporation Trust Center, Cardinal Health, Inc. c/o CT Corporation System, Cephalon Inc. Corporate Creations Network, Inc., Endo Health Solutions Inc. c/o The Corporation Trust Company Corporation Trust Center, Endo Pharmaceuticals Inc.c/o CT Corporation System, Insys Therapeutics, Inc. c/o CT Corporation System, Janssen Pharmaceuticals, Inc. c/o CT Corporation System, Johnson & Johnson, Knoll Pharmaceutical Company, McKesson Corporation c/o CSC - Lawyers Incorporating Service, Pfizer, Inc. c/o CT Corporation System, Purdue Pharma Inc. c/o Corporation Service Company, Purdue Pharma L.P. c/o The Prentice-Hall Corporation System, Inc., Teva Pharmaceuticals USA, Inc. c/o Corporate Creations Network, Inc., The Purdue Frederick Company c/o The Prentice-Hall Corporation System, Inc., Watson Laboratories, Inc. c/o Corporate Creations Network, Inc,.(nkl, ) [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Summons(es) Actavis LLC,
|
||
|
Att: 2
Summons(es) Actavis Pharma Inc.,
|
||
|
Att: 3
Summons(es) Allergan Finance LLC,
|
||
|
Att: 4
Summons(es) AmerisourceBergen Corporation,
|
||
|
Att: 5
Summons(es) Cardinal Health Inc.,
|
||
|
Att: 6
Summons(es) Cephalon Inc.,
|
||
|
Att: 7
Summons(es) Endo Health Solutions Inc.,
|
||
|
Att: 8
Summons(es) Endo Pharmaceuticals Inc.,
|
||
|
Att: 9
Summons(es) Insys Therapeutics Inc.,
|
||
|
Att: 10
Summons(es) Janssen Pharmaceuticals Inc.,
|
||
|
Att: 11
Summons(es) Johnson & Johnson,
|
||
|
Att: 12
Summons(es) Knoll Pharmaceutical Company,
|
||
|
Att: 13
Summons(es) McKesson Corporation,
|
||
|
Att: 14
Summons(es) Pfizer Inc.,
|
||
|
Att: 15
Summons(es) Purdue Pharma Inc.,
|
||
|
Att: 16
Summons(es) Purdue Pharma L.P.,
|
||
|
Att: 17
Summons(es) Watson Laboratories,
|
||
|
Att: 18
Summons(es) Teva Pharmaceuticals USA Inc.,
|
||
|
Att: 19
Summons(es) The Purdue Frederick Company
|
||
| Monday, October 09, 2017 | ||
| 5 | 5
NOTICE of Designation of Attorney in Charge to Jeffrey Blake Simon on behalf of County of Upshur (Simon, Jeffrey) [Transferred from txed on 12/15/2017.]
|
|
| Wednesday, October 11, 2017 | ||
| 6 | 6
ORDER OF RECUSAL. Judge Rodney Gilstrap recused. Case reassigned to Judge Robert W. Schroeder, III for all further proceedings. Signed by Judge Rodney Gilstrap on 10/11/2017. (nkl, ) [Transferred from txed on 12/15/2017.]
|
|
| Thursday, October 19, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 11/26/2017. 30 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 12/11/2017. 15 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| 7 | 7
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/15/2017.]
|
|
| 8 | 8
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/15/2017.]
|
|
| 9 | 9
Joint MOTION for Extension of Time to File Answer to Claims Against Pfizer Inc. by Pfizer, Inc..(Burbach, Edward) [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Text of Proposed Order Proposed Order
|
||
| Monday, October 23, 2017 | ||
| 10 | 10
CORPORATE DISCLOSURE STATEMENT filed by Pfizer, Inc. (Burbach, Edward) [Transferred from txed on 12/15/2017.]
|
|
| 11 | 11
NOTICE of Attorney Appearance by Stephen Edward McConnico on behalf of Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 12 | 12
CORPORATE DISCLOSURE STATEMENT filed by Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc.. (McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| Tuesday, October 24, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for McKesson Corporation to 11/24/2017. 30 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Allergan Finance LLC to 11/27/2017. 30 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for McKesson Corporation to 12/9/2017. 15 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| 13 | 13
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/15/2017.]
|
|
| 14 | 14
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/15/2017.]
|
|
| 15 | 15
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/15/2017.]
|
|
| 16 | 16
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 17 | 17
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 18 | 18
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 19 | 19
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Johnson & Johnson.( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 20 | 20
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc..( Sarokhanian, Nicholas) [Transferred from txed on 12/15/2017.]
|
|
| 21 | 21
CORPORATE DISCLOSURE STATEMENT filed by Insys Therapeutics, Inc. (Sarokhanian, Nicholas) [Transferred from txed on 12/15/2017.]
|
|
| Wednesday, October 25, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Janssen Pharmaceutica Inc. to 11/24/2017. 29 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Janssen Pharmaceuticals, Inc. to 11/24/2017. 29 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Ortho-McNeil-Janssen Pharmaceuticals, Inc. to 11/24/2017. 29 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Johnson & Johnson to 11/24/2017. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 11/25/2017. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Endo Pharmaceuticals Inc. to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Endo Health Solutions Inc. to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Pharmaceuticals Inc. to 12/12/2017. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Health Solutions Inc. to 12/12/2017. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Abbott Laboratories to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 12/12/2017. 15 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Purdue Pharma Inc to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for The Purdue Frederick Company to 11/27/2017. 30 Days Granted for Deadline Extension.( nkl, ) [Transferred from txed on 12/15/2017.] | ||
| 22 | 22
CORPORATE DISCLOSURE STATEMENT filed by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Sibiski, Hannah) [Transferred from txed on 12/15/2017.]
|
|
| 23 | 23
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals Inc..( Sibiski, Hannah) [Transferred from txed on 12/15/2017.]
|
|
| 24 | 24
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Health Solutions Inc..( Sibiski, Hannah) [Transferred from txed on 12/15/2017.]
|
|
| 25 | 25
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals Inc..( Sibiski, Hannah) [Transferred from txed on 12/15/2017.]
|
|
| 26 | 26
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Health Solutions Inc..( Sibiski, Hannah) [Transferred from txed on 12/15/2017.]
|
|
| 27 | 27
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Abbott Laboratories.( Ertas, Alper) [Transferred from txed on 12/15/2017.]
|
|
| 28 | 28
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/15/2017.]
|
|
| 29 | 29
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/15/2017.]
|
|
| 30 | 30
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 12/15/2017.]
|
|
| 31 | 31
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/15/2017.]
|
|
| 32 | 32
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/15/2017.]
|
|
| 33 | 33
CORPORATE DISCLOSURE STATEMENT filed by Purdue Pharma Inc, Purdue Pharma L.P., The Purdue Frederick Company [Transferred from txed on 12/15/2017.]
|
|
| Thursday, October 26, 2017 | ||
| Answer Due Deadline Updated for Pfizer, Inc. to 1/8/2018. (nkl, ) [Transferred from txed on 12/15/2017.] | ||
| 34 | 34
ORDER granting9 Motion for Extension of Time to Answer. Signed by District Judge Robert W. Schroeder, III on 10/26/2017. (nkl, ) [Transferred from txed on 12/15/2017.]
|
|
| 35 | 35
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Watson Laboratories, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 36 | 36
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Watson Laboratories, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 37 | 37
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis LLC.( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 38 | 38
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Actavis LLC.( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 39 | 39
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Teva Pharmaceuticals USA, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 40 | 40
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Teva Pharmaceuticals USA, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 41 | 41
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cephalon Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 42 | 42
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cephalon Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 43 | 43
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 44 | 44
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 45 | 45
CORPORATE DISCLOSURE STATEMENT filed by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc. identifying Corporate Parent Teva Pharmaceuticals, Ltd. for Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| 46 | 46
CORPORATE DISCLOSURE STATEMENT filed by Cephalon Inc., Teva Pharmaceuticals USA, Inc. (Stanfield, Craig) [Transferred from txed on 12/15/2017.]
|
|
| Friday, October 27, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Teva Pharmaceuticals USA, Inc. to 11/25/2017; Actavis Pharma, Inc. to 11/25/2017; Actavis LLC to 11/25/2017; Watson Laboratories, Inc. to 11/25/2017; Cephalon Inc. to 11/25/2017. 30 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Teva Pharmaceuticals USA, Inc. to 12/10/2017; Actavis Pharma, Inc. to 12/10/2017; Actavis LLC to 12/10/2017; Watson Laboratories, Inc. to 12/10/2017; Cephalon Inc. to 12/10/2017. 15 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Allergan Finance LLC to 12/12/2017. 15 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| 47 | 47
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/15/2017.]
|
|
| 48 | 48
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 12/15/2017.]
|
|
| 49 | 49
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/15/2017.]
|
|
| 50 | 50
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/15/2017.]
|
|
| 51 | 51
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc..( Sarokhanian, Nicholas) [Transferred from txed on 12/15/2017.]
|
|
| 52 | 52
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 53 | 53
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 54 | 54
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| 55 | 55
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Johnson & Johnson.( McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
| Monday, October 30, 2017 | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma Inc to 12/10/2017. 13 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 12/10/2017. 13 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for The Purdue Frederick Company to 12/10/2017. 13 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 12/10/2017; Janssen Pharmaceuticals, Inc. to 12/8/2017; Janssen Pharmaceutica Inc. to 12/8/2017; Johnson & Johnson to 12/8/2017; Ortho-McNeil-Janssen Pharmaceuticals, Inc. to 12/8/2017. 14 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| Tuesday, October 31, 2017 | ||
| 56 | 56
NOTICE of Attorney Appearance - Pro Hac Vice by Charles C. Lifland on behalf of Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. Filing fee $ 100, receipt number 0540-6533325. (Lifland, Charles) [Transferred from txed on 12/15/2017.]
|
|
| Monday, November 13, 2017 | ||
| 57 | 57
SUMMONS Issued as to Knoll Pharmaceutical Company c/o The Corporation Trust Company. (nkl, ) [Transferred from txed on 12/15/2017.]
|
|
| Wednesday, November 15, 2017 | ||
| 58 | 58
STIPULATION of Dismissal of Defendant Pfizer, Inc. by County of Upshur. (Simon, Jeffrey) (sm, ). [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
(11/15/2017) Text of Proposed Order
|
||
| Thursday, November 16, 2017 | ||
| 59 | 59
ORDER OF DISMISSAL re58 Stipulation of Dismissal filed by County of Upshur ORDERING that Plaintiff's claims against Defendant Pfizer, Inc. are Dismissed Without Prejudice. Signed by District Judge Robert W. Schroeder, III on 11/16/2017. (sm, ) [Transferred from txed on 12/15/2017.]
|
|
| Tuesday, November 21, 2017 | ||
| 60 | 60
NOTICE of Attorney Appearance by Amy M. Carter on behalf of County of Upshur (Carter, Amy) [Transferred from txed on 12/15/2017.]
|
|
| Wednesday, November 22, 2017 | ||
| 61 | 61
First MOTION for Extension of Time to File Answer by Abbott Laboratories.(Ertas, Alper) [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Text of Proposed Order
|
||
| Monday, November 27, 2017 | ||
| 62 | 62
Joint MOTION for Extension of Time to File Answer re61 First MOTION for Extension of Time to File Answer by Abbott Laboratories.(Ertas, Alper) (sm, ). [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Text of Proposed Order
|
||
|
Att: 2
(11/28/2017) Revised order (no lines)
|
||
| Tuesday, November 28, 2017 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Knoll Pharmaceutical Company to 1/5/2018. 25 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] | ||
| 63 | 63
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Knoll Pharmaceutical Company.( Wilkes, John) [Transferred from txed on 12/15/2017.]
|
|
| Thursday, November 30, 2017 | ||
| 64 | 64
CORPORATE DISCLOSURE STATEMENT filed by AmerisourceBergen Corporation (Smith, Melissa) [Transferred from txed on 12/15/2017.]
|
|
| Thursday, December 07, 2017 | ||
| 65 | 65
NOTICE of Attorney Appearance - Pro Hac Vice by James K. O'Connor on behalf of Abbott Laboratories. Filing fee $ 100, receipt number 0540-6579511. (O'Connor, James) [Transferred from txed on 12/15/2017.]
|
|
| 66 | 66
NOTICE of Attorney Appearance - Pro Hac Vice by John A McCauley on behalf of Abbott Laboratories. Filing fee $ 100, receipt number 0540-6579639. (McCauley, John) [Transferred from txed on 12/15/2017.]
|
|
| Friday, December 08, 2017 | ||
| 67 | 67
Joint MOTION to Stay Plaintiff's and Served Defendants' by Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc..(McConnico, Stephen) [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Text of Proposed Order
|
||
| 68 | 68
MOTION for Extension of Time to File Response/Reply by McKesson Corporation.(Scott, Robert) (sm, ). [Transferred from txed on 12/15/2017.]
|
|
|
Att: 1
Text of Proposed Order
|
||
|
Att: 2
(12/11/2017) Revised Order (no lines)
|
||
| Thursday, December 14, 2017 | ||
| 69 | 69
CONDITIONAL TRANSFER ORDER (CTO-1)(ch, ) [Transferred from txed on 12/15/2017.]
|
|
| Friday, December 15, 2017 | ||
| Interdistrict transfer to the Northern District of Ohio. (ch, ) [Transferred from txed on 12/15/2017.] | ||
| 70 | 70
CASE TRANSFERRED IN from District of Texas Eastern. Case number 2:17-cv-00672. Electronic file and copy of transfer order and docket sheet received.
|
|